Contractors open shop; India checks its exporters;

> NextPharma's Sterile Product Development Center outside of Brussels is now in business, having shipped its first formulated, manufactured and labeled GMP drug candidate for the trial of a controlled-release, anhydrous and lipid based formulation. Release

> Waymade Healthcare has cut the ribbon on a specialty-medication manufacturing facility, targeting drugs made for patients with such special needs as allergies to common pharma ingredients. Article

> Regulators in India are clamping down on drug exporters. Blog

> Berlin-based process-management solutions provider Pumacy Technologies has developed the KMmaster Life Science Edition as part of the EU's BIOsecure project for quality assurance. Release

> MWB Consulting, which advises international clients on development and postmarketing support of pharmaceuticals and medical devices, has joined SAFE-BioPharma Association. Announcement


Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.